Written by Private MD Labs Medical Writing Team • Last Updated: September 8, 2025
Venous thromboembolism (VTE) encompasses both deep vein thrombosis (DVT) and pulmonary embolism (PE), conditions where blood clots form in veins. While VTE is primarily diagnosed through imaging studies, blood tests play a crucial role in identifying underlying genetic and protein abnormalities that increase the risk of developing these dangerous clots.
This genetic test identifies the Factor V Leiden mutation, one of the most common inherited risk factors for venous thromboembolism. The mutation causes hypercoagulability, making blood clot more easily than normal and substantially increasing the risk of developing dangerous blood clots in veins.
Blood tests for VTE focus on detecting inherited or acquired conditions that predispose individuals to hypercoagulability - a state where blood clots more easily than normal. These tests are fundamental for assessing thrombophilia (clotting disorders), guiding long-term anticoagulation decisions, and screening family members who may be at risk.
This test measures free protein S levels, which is part of the body's natural anticoagulant system that helps prevent inappropriate clot formation. Low levels of free protein S antigen can significantly increase the risk of venous thromboembolism by reducing the body's ability to regulate blood clotting properly.
These blood tests are typically recommended for individuals who have experienced unexplained VTE, recurrent clotting episodes, clots at a young age, or have a strong family history of thrombotic events. The results help healthcare providers understand underlying risk factors and develop appropriate prevention strategies.
The information here is for educational purposes only and is not a substitute for professional medical advice. Always consult with a healthcare provider for diagnosis and treatment.